Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-04-21
1988-06-14
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540594, 540595, C07D40702, A61K 3155
Patent
active
047512229
ABSTRACT:
Novel 2,3,4,5-tetrahydro-1H-3-benzazepines which in the 5-position have furyl, thienyl, pyridyl, or ring systems consisting of phenyl ortho condensed with a benzen, cyclohexan, cyclohexen, cyclopentan or cyclopenten ring wherein one of the carbon atoms may be exchanged with oxygen, sulphur or nitrogen, have interesting central nervous system and cardiovascular effects.
REFERENCES:
patent: 3393192 (1968-07-01), Walter et al.
patent: 4111957 (1978-09-01), Holden et al.
patent: 4284555 (1981-08-01), Gold et al.
Andersen Peter H.
Borrevang Poul
Braestrup Claus
Gr nvald Frederik C.
Hansen Louis B.
Fidelman Morris
Hollrah Glennon H.
Novo Industri A/S
Springer D. B.
Wolffe Franklin D.
LandOfFree
2,3,4,5-tetrahydro-1H-3-benzazepines and CNS affecting use there does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3,4,5-tetrahydro-1H-3-benzazepines and CNS affecting use there, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3,4,5-tetrahydro-1H-3-benzazepines and CNS affecting use there will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505234